Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00603408
What this trial is testing

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Washington University School of Medicine 5
Not applicableEnded earlyNCT04835597
What this trial is testing

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)UnknownNCT05747313
What this trial is testing

Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Ended earlyNCT05388435
What this trial is testing

Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Who this might be right for
Advanced Solid Tumor
SK Life Science, Inc. 15
Early research (Phase 1)Study completedNCT01884285
What this trial is testing

AZD8186 First Time In Patient Ascending Dose Study

Who this might be right for
Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC
AstraZeneca 147
Not applicableUnknownNCT02448576
What this trial is testing

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

Who this might be right for
Breast CancerBrain Metastasis
wang shusen 326
Large-scale testing (Phase 3)Looking for participantsNCT06732323
What this trial is testing

A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Qilu Pharmaceutical Co., Ltd. 504
Early research (Phase 1)Looking for participantsNCT06347068
What this trial is testing

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Who this might be right for
Breast CancerRelapseResistant Cancer+1 more
UNC Lineberger Comprehensive Cancer Center 42
Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Testing effectiveness (Phase 2)Study completedNCT00600249
What this trial is testing

Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.

Who this might be right for
Breast Cancer
Centre Jean Perrin 35
Not applicableStudy completedNCT01461044
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 228
Large-scale testing (Phase 3)Active Not RecruitingNCT01057069
What this trial is testing

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 310
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06731153
What this trial is testing

JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC

Who this might be right for
Triple Negative Breast Cancer (TNBC)Metastatic Breast Cancer
Fudan University 40
Testing effectiveness (Phase 2)WithdrawnNCT05233696
What this trial is testing

Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC

Who this might be right for
Triple Negative Breast CancerLocally Advanced Breast CancerUnresectable Breast Carcinoma+2 more
University of Colorado, Denver
Early research (Phase 1)Study completedNCT00516724
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Who this might be right for
Triple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more
AstraZeneca 189
Early research (Phase 1)Ended earlyNCT02078752
What this trial is testing

PF-06647263 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsTriple-Negative Breast Cancer
Pfizer 60
Early research (Phase 1)Ended earlyNCT04139993
What this trial is testing

RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Mayo Clinic 3
Testing effectiveness (Phase 2)Study completedNCT02489448
What this trial is testing

Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Yale University 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03915678
What this trial is testing

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic CancerVirus-associated Tumors+4 more
Institut Bergonié 247
Testing effectiveness (Phase 2)WithdrawnNCT02685306
What this trial is testing

Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast NeoplasmsTriple-Negative Breast Neoplasm+4 more
Peregrine Pharmaceuticals
Next Page